Dysregulation of the epidermal growth factor receptor (EGFR) pathway has a role in numerous kidney diseases. This Review explores the function of the EGFR pathway in renal physiology and pathology and the clinical potential of targeting this signalling pathway as a therapeutic strategy to treat kidney diseases.
- Laura R. Harskamp
- Ron T. Gansevoort
- Esther Meijer